Pharmacology Management of Asthma

The current concept of asthma therapy is based on a stepwise approach, depending on disease severity, and the aim is to reduce the symptoms that result from airway obstruction and inflammation, to prevent exacerbations and to maintain normal lung function. Beta adrenoceptor agonists and glucocorticoids are at present the most effective drugs for the treatment of airway obstruction and inflammation, with theophylline, leukotriene receptor antagonists and anticholinergic as second- or third-line therapy. There are, to date, no additional or newly developed drugs available that add substantially to the current strategies or even replace β2 adrenoceptor  agonists or glucocorticoids. New approaches in asthma therapy recommend drug combinations of inhaled steroids, primarily with long-acting β2 adrenoceptor agonists, based on their improved efficacy and the potential for a steroid-sparing effect.

  • Asthma
  • Asthma: Immunopathology
  • Biologics of Asthma
  • Biomarkers for Asthma & Clinical Immunology
  • Asthma and Pregnancy
  • Asthma and advanced Asthma Treatment

Related Conference of Pharmacology Management of Asthma

June 11-12, 2024

31st Global Nursing and Health Care Conference

Amsterdam, Netherlands
June 20-21, 2024

55th World Nursing and Healthcare Conference

Dublin, Ireland
June 27-28, 2024

61st World Nursing Conference

London, UK
July 18-19, 2024

31st Global Nursing and Healthcare Congress

Paris, France
August 08-09, 2024

43rd World Nursing and Healthcare Conference

London, UK
September 04-05, 2024

World Nursing Congress

Toronto, Canada
October 10-11, 2024

16th International Conference on Gynecology

Madrid, Spain
December 04-05, 2024

4th Global Summit on Nursing Practice

Orlando, USA

Pharmacology Management of Asthma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in